All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference. For example, this application incorporates by reference in their entireties U.S. Patent Publication No. 2011/0087294, U.S. Patent Publication No. 2011/0087296, U.S. Patent Publication No. 2011/0118785, and U.S. Patent Publication No. 2011/0125268.
The present disclosure generally relates to bone implants. More specifically, the present disclosure relates to bone implants used for the stabilization, fixation and/or fusion of the sacroiliac joint and/or the spine.
Many types of hardware are available both for the fixation of bones that are fractured and for the fixation of bones that are to be fused (arthrodesed).
For example, the human hip girdle is made up of three large bones joined by three relatively immobile joints. One of the bones is called the sacrum and it lies at the bottom of the lumbar spine, where it connects with the L5 vertebra. The other two bones are commonly called “hip bones” and are technically referred to as the right ilium and—the left ilium. The sacrum connects with both hip bones at the sacroiliac joint (in shorthand, the SI-Joint).
The SI-Joint functions in the transmission of forces from the spine to the lower extremities, and vice-versa. The SI-Joint has been described as a pain generator for up to 22% of lower back pain.
To relieve pain generated from the SI-Joint, sacroiliac joint fusion is typically indicated as surgical treatment, e.g., for degenerative sacroiliitis, inflammatory sacroiliitis, iatrogenic instability of the sacroiliac joint, osteitis condensans ilii, or traumatic fracture dislocation of the pelvis. Currently, screws and screws with plates are used for sacroiliac fusion. At the same time the cartilage is generally removed from the “synovial joint” portion of the SI-Joint. This requires a large incision to approach the damaged, subluxed, dislocated, fractured, or degenerative joint.
Additionally, long constructs can be used to join, fuse and/or stabilize a plurality of vertebrae in the thoracic, lumbar, and sacral portions of the spine. These long constructs may include one or more rods. For example, to treat spinal disorders such as degenerative scoliosis, the L5 vertebra to the S1 vertebrae can be fused using a system of implants and rods as described herein.
The disclosure herein generally relates to one or more of bone implants, their methods of use, or their methods of assembly. The implants herein may be used in one or both of the treatment of a SI-Joint, or as an anchoring component for a construct that joins, fuses and/or stabilizes vertebrae.
One aspect of the disclosure is an implant for use in at least one of bone fusion or stabilizing a plurality of bones. The implant includes a distal anchoring region and a growth region that is proximal to the distal anchoring region, the distal anchoring region having one or more distal surface features that adapt the distal anchoring region for anchoring into iliac bone, and the growth region includes one or more growth features that adapt the growth region to facilitate at least one of bony on-growth, in-growth, or through-growth.
The implant is optionally a composite implant. A composite implant may have an inner elongate member such as a shank and an outer elongate member such as a sleeve. An inner shank may have a distal end region with one or more threads sized and configured for anchoring into iliac bone. An outer sleeve can be sized and configured to be positioned over at least a portion of the inner shank. A sleeve may be positioned relative to an inner member to form a composite implant with an inner member interface feature and a sleeve interface feature interfacing each other so as to resist relative motion between the sleeve and the inner member in at least one direction.
A distal anchoring region can have one or more distal surface features that better adapt the distal anchoring region for anchoring into iliac bone than the growth region, and the growth region can have one or more growth features that better adapt the growth region to facilitate at least one of bony on-growth, in-growth, or through-growth than the anchoring region.
An inner member (e.g. an inner shank) may be more resistant to fatigue than an outer member (e.g. an outer sleeve).
The implants herein are optionally not composite implants.
One aspect of the disclosure herein includes a method of implanting an implant, optionally a composite implant, for use in at least one of fusing or stabilizing bony tissue. The method includes advancing the implant along a posterior sacral alar-iliac (“SAI”) trajectory until a distal anchoring region is disposed in iliac bone and growth region is disposed across the SI Joint. The method can include coupling a tulip or other coupling member to the implant, and optionally coupling a construct member (e.g. rod), to the tulip.
One aspect of the disclosure is a method of assembling a composite bone implant for use in one or more of fusing or stabilizing bone. The method includes positioning an outer member (e.g. sleeve) such that the outer member is disposed over an inner member (e.g. inner shank). Forming the composite implant may include forming a composite implant such that an inner member (e.g. shank) interface feature and a sleeve interface feature interface each other so as to resist relative motion between the sleeve and the inner member in at least one direction. A composite implant may have a distal anchoring region and a growth region that is proximal to the distal anchoring region, the distal anchoring region optionally having one or more distal surface features that better adapt the distal anchoring region for anchoring into iliac bone than the growth region, and the growth region optionally having one or more growth features that better adapt the growth region to facilitate at least one of bony on-growth, in-growth, or through-growth than the anchoring region.
One aspect of the disclosure is an inner shank that can be used as part of a composite bone implant. The inner shank can include any of the features described or claimed herein.
One aspect of the disclosure is an outer sleeve that can be used as part of a composite bone implant. The outer sleeve can include any of the features described or claimed herein.
In some merely exemplary embodiments, an implant for use in fusing and or stabilizing a plurality of bones is provided with a shank portion, a body portion and a head portion. The shank portion has a proximal end and a distal end. The body portion is coupled to the shank portion and is configured to be placed through a first bone segment, across a bone joint or fracture and into a second bone segment. The body portion is configured to allow for bony on-growth, ingrowth and through-growth. The head portion is coupled to the proximal end of the shank portion and is configured to couple the shank portion to a stabilizing rod.
A body portions as used in this context may include any of the sleeves herein.
In some embodiments of the above implants, the distal end of the shank portion is provided with threads for securing the implant to the second bone segment. In some embodiments, the first bone segment is a sacrum and the second bone segment is an ilium. The body portion may be integral with the shank portion. The body portion may include at least one rectilinear face to prevent rotation. In some embodiments, the body portion has a cross-section transverse to a longitudinal axis that is triangular in shape to prevent rotation. The body portion may include at least one apex to prevent rotation. In some embodiments, the body portion includes a plurality of fenestrations that each communicate with a central lumen of the body portion. The shank portion may include at least one spline that mates with a slot within the body portion to prevent relative rotation between the shank portion and the body portion.
In some embodiments, an implant for use in fusing and or stabilizing a plurality of bones is provided with a shank portion, a body portion and a head portion. The shank portion has a proximal end and a distal end. The body portion is coupled to the shank portion and is configured to be placed into a first bone segment. The body portion is configured to allow for bony on-growth, ingrowth and through-growth. The head portion is coupled to the proximal end of the shank portion and is configured to couple the shank portion to a stabilizing rod.
In some embodiments, the first bone segment is a vertebra, a sacrum or an ilium. The distal end of the shank portion may be provided with threads for securing the implant to the second bone segment. In some embodiments, the body portion is integral with the shank portion. In some embodiments, the body portion includes at least one rectilinear face to prevent rotation. The body portion may have a cross-section transverse to a longitudinal axis that is triangular in shape to prevent rotation. In some embodiments, the body portion includes at least one apex to prevent rotation. The body portion may include a plurality of fenestrations that each communicate with a central lumen of the body portion. In some embodiments, the shank portion includes at least one spline that mates with a slot within the body portion to prevent relative rotation between the shank portion and the body portion. The distal end of the shank portion may be provided with a plurality of bristles to allow the shank portion to be distally inserted into a bone but inhibit proximal removal from the bone.
One aspect of the disclosure is an implant for use in at least one of fusing or stabilizing bony tissue, comprising: an elongate body sized and configured such that the elongate body can be implanted across a sacro-iliac (“SI”) joint and extend into a sacrum and into an ilium (optionally to or beyond a tear-drop shaped region); a distal anchoring region of the elongate body having one or more distal surface features that are configured to anchor the distal anchoring region to iliac bone, and a proximal region of the elongate body disposed proximal to the distal region, the proximal region having one or more proximal surface features adapted to allow at least one of bony on-growth, in-growth, or through-growth.
One aspect of this disclosure is a bone stabilizing implant, comprising: an elongate implant body; and one or more deployable members, the one or more deployable members each having a non-deployed position and a deployed position relative to the elongate implant body. An elongate implant body can include one or more threads, optionally a plurality of regions having different number of leads. An elongate implant can include a plurality of rows of openings (optionally linear rows), each of the rows including a plurality of openings separated by a portion of the elongate implant body. A portion of the elongate implant body that separates the plurality of openings can include one or more threads. Any of the deployable members can include a plurality of protrusions extending from a spine, the protrusions extending further radially outward than the spine, and optionally the protrusions formed integrally with the spine. One or more deployable members can be positioned relative to the elongate implant body such that they are deployed upon actuation of an internal deployment member. An internal deployment member can comprise a plurality of radially protruding camming surfaces that when rotated cause the one or more deployable members to move radially outward. One or more threads on an elongate implant body can provide a mechanical radial stop to one or more deployable members, optionally preventing the opening(s) from bowing under load. Any of the openings may be tapered to limit play between an elongate implant body and one or more deployable members. An elongate implant body can have one or more lattice sections.
Elongated, stem-like implant structures 20 like that shown in
In one embodiment of a lateral approach (see
Before undertaking a lateral implantation procedure, the physician identifies the SI-Joint segments that are to be fixated or fused (arthrodesed) using, e.g., the Fortin finger test, thigh thrust, FABER, Gaenslen's, compression, distraction, and diagnostic SI-Joint injection.
Aided by lateral, inlet, and outlet C-arm views, and with the patient lying in a prone position, the physician aligns the greater sciatic notches and then the alae (using lateral visualization) to provide a true lateral position. A 3 cm incision is made starting aligned with the posterior cortex of the sacral canal, followed by blunt tissue separation to the ilium. From the lateral view, the guide pin 38 (with sleeve (not shown)) (e.g., a Steinmann Pin) is started resting on the ilium at a position inferior to the sacrum end plate and just anterior to the sacral canal. In the outlet view, the guide pin 38 should be parallel to the sacrum end plate and in the inlet view the guide pin 38 should be at a shallow angle anterior (e.g., 15 degrees to 20 degrees off the floor, as
Over the guide pin 38 (and through the soft tissue protector), the pilot bore 42 is drilled in the manner previously described, as is diagrammatically shown in
The shaped broach 44 is tapped into the pilot bore 42 over the guide pin 38 (and through the soft tissue protector) to create a broached bore 48 with the desired profile for the implant structure 20, which, in the illustrated embodiment, is triangular. This generally corresponds to the sequence shown diagrammatically in
In some embodiments, a dilator can be used to open a channel though the tissue prior to sliding the soft tissue protector assembly 210 over the guide pin. The dilator(s) can be placed over the guide pin, using for example a plurality of sequentially larger dilators or using an expandable dilator. After the channel has been formed through the tissue, the dilator(s) can be removed and the soft tissue protector assembly can be slid over the guide pin. In some embodiments, the expandable dilator can serve as a soft tissue protector after being expanded. For example, after expansion the drill sleeve and guide pin sleeve can be inserted into the expandable dilator.
As shown in
The implant structures 20 are sized according to the local anatomy. For the SI-Joint, representative implant structures 20 can range in size, depending upon the local anatomy, from about 35 mm to about 60 mm in length, and about a 7 mm inscribed diameter (i.e. a triangle having a height of about 10.5 mm and a base of about 12 mm). The morphology of the local structures can be generally understood by medical professionals using textbooks of human skeletal anatomy along with their knowledge of the site and its disease or injury. The physician is also able to ascertain the dimensions of the implant structure 20 based upon prior analysis of the morphology of the targeted bone using, for example, plain film x-ray, fluoroscopic x-ray, or MRI or CT scanning.
Using a lateral approach, one or more implant structures 20 can be individually inserted in a minimally invasive fashion across the SI-Joint, as has been described. Conventional tissue access tools, obturators, cannulas, and/or drills can be used for this purpose. Alternatively, the novel tissue access tools described above and in U.S. Application No. 61/609,043, titled “TISSUE DILATOR AND PROTECTOR” and filed Mar. 9, 2012, which is hereby incorporated by reference in its entirety, can also be used. No joint preparation, removal of cartilage, or scraping are required before formation of the insertion path or insertion of the implant structures 20, so a minimally invasive insertion path sized approximately at or about the maximum outer diameter of the implant structures 20 can be formed.
The implant structures 20 can obviate the need for autologous bone graft material, additional pedicle screws and/or rods, hollow modular anchorage screws, cannulated compression screws, threaded cages within the joint, or fracture fixation screws. Still, in the physician's discretion, bone graft material and other fixation instrumentation can be used in combination with the implant structures 20.
In a representative procedure, one to six, or perhaps up to eight, implant structures 20 can be used, depending on the size of the patient and the size of the implant structures 20. After installation, the patient would be advised to prevent or reduce loading of the SI-Joint while fusion occurs. This could be about a six to twelve week period or more, depending on the health of the patient and his or her adherence to post-op protocol.
The implant structures 20 make possible surgical techniques that are less invasive than traditional open surgery with no extensive soft tissue stripping. The lateral approach to the SI-Joint provides a straightforward surgical approach that complements the minimally invasive surgical techniques. The profile and design of the implant structures 20 minimize or reduce rotation and micromotion. Rigid implant structures 20 made from titanium provide immediate post-op SI-Joint stability. A bony in-growth region 24 comprising a porous plasma spray coating with irregular surface supports stable bone fixation/fusion. The implant structures 20 and surgical approaches make possible the placement of larger fusion surface areas designed to maximize post-surgical weight bearing capacity and provide a biomechanically rigorous implant designed specifically to stabilize the heavily loaded SI-Joint.
To improve the stability and weight bearing capacity of the implant, the implant can be inserted across three or more cortical walls. For example, after insertion the implant can traverse two cortical walls of the ilium and at least one cortical wall of the sacrum. The cortical bone is much denser and stronger than cancellous bone and can better withstand the large stresses found in the SI-Joint. By crossing three or more cortical walls, the implant can spread the load across more load bearing structures, thereby reducing the amount of load borne by each structure. In addition, movement of the implant within the bone after implantation is reduced by providing structural support in three locations around the implant versus two locations.
In some embodiments, the implant structure can function like a pedicle screw to allow fixation and/or fusion of bone such as the spine and/or SI-Joint. For example, long constructs can be used to join, fuse and/or stabilize a plurality of vertebrae in the thoracic, lumbar, and sacral portions of the spine. For example, to treat spinal disorders such as degenerative scoliosis, the L5 vertebra to the S1 vertebrae can be fused using a system of implants and rods as described herein. As illustrated in
In some embodiments, as illustrated in
In some embodiments as illustrated in
In some embodiments as illustrated in
In some embodiments that may be particularly suited for pedicle screw salvage as illustrated in
In some embodiments, the head portion receiving slot 1858 runs up both a portion of one of the side walls and the along the bottom portion to the opening 1860. In some embodiments, the upper portion of the head portion receiving slot 1858 can be circular in shape to accommodate the ball portion of the head portion 1804. The circular portion of the head portion receiving slot 1858 can be located a sufficient distance from the bottom portion of the tulip structure 1850 such that after the ball portion of the head portion 1804 passes into the cavity of the tulip structure 1850, the ball portion drops down against the bottom portion which prevents the ball portion from inadvertently sliding out of the tulip structure 1850. In order for the ball portion of the head portion 1804 to be removed from the tulip structure 1850, the ball portion must be raised from the bottom of the tulip structure 1850 until the ball portion is aligned with the circular portion of the head portion receiving slot 1858, and then the head portion 1804 can be removed from the tulip structure. In some embodiments, the portion of the head portion receiving slot 1858 on the bottom part of the tulip structure can be a straight slot. In other embodiments, the portion of the head portion receiving slot 1858 on the bottom part of the tulip structure can be a curved slot.
The shape and structure of the tulip structure 1850 cavity and opening 1860 allows the tulip structure 1850 to have about a 60 degree angle of movement and rotation after being attached to the head portion 1804. Such a tulip structure 1850 and head portion 1804 can be referred to as poly-axial, meaning the tulip structure 1850 can freely move within a conical area. In other embodiments, the angle of movement and rotation can be between about 30 to 90 degrees or less. Having a substantial angle of movement and rotation allows the implant structure 1800 to be inserted in a wider variety of angles while still allowing the tulip structure 1850 to be aligned with the rod for fixation.
Any of the implants described herein can be used in a variety of surgical procedures, such as stabilization, fixation or fusion of the sacroiliac joint and/or the spine, including vertebra and facet joints. In addition, surgical procedures using a posterior or a posterolateral approach will be particularly suitable for use with the implant structures described herein since the tulip structure of the implant will be aligned with the other implants along the spine after implantation. As described herein, these implant structures can be connected together using a rod that can be secured to each tulip structure. For simplicity, the following procedures will be illustrated and described using a general implant structure 20, but it is understood that any of the implant structures described herein can be used in place of the general implant structure 20.
For example,
The posterolateral approach involves less soft tissue disruption that the lateral approach, because there is less soft tissue overlying the entry point of the posterior iliac spine of the ilium. Introduction of the implant structure 20 from this region therefore makes possible a smaller, more mobile incision. Further, the implant structure 20 passes through more bone along the posterolateral route than in a strictly lateral route, thereby involving more surface area of the SI-Joint and resulting in more fusion and better fixation of the SI-Joint. Employing the posterolateral approach also makes it possible to bypass all nerve roots, including the L5 nerve root.
The set-up for a posterolateral approach is generally the same as for a lateral approach. It desirably involves the identification of the SI-Joint segments that are to be fixated or fused (arthrodesed) using, e.g., the Faber Test, or CT-guided injection, or X-ray/MRI of SI-Joint. It is desirable performed with the patient lying in a prone position (on their stomach) and is aided by lateral and anterior-posterior (A-P) c-arms. The same surgical tools are used to form the pilot bore 42 over a guide pin 38, except the path of the pilot bore 42 now starts from the posterior iliac spine of the ilium, angles through the SI-Joint, and terminates in the sacral alae. The pilot bore 42 is shaped into the desired profile using a broach, as before described, and the implant structure 20 is inserted into the broached bore 48. The implant structure 20 is tapped through the soft tissue protector over the guide pin 38 from the posterior iliac spine of the ilium, angling through the SI-Joint, and terminating in the sacral alae, until the proximal end of the implant structure 20 is flush against the posterior iliac spine of the ilium. Because of the anatomic morphology of the bone along the posterolateral route, it may be advisable to introduce implant structures of difference sizes, with the most superior being the longest in length, and the others being smaller in length.
As can be seen in the representative embodiment illustrated in
The first and second implant structures 20 are sized and configured according to the local anatomy. The selection of a translaminar lumbar fusion (posterior approach) is indicated when the facet joints are aligned with the sagittal plane. Removal of the intervertebral disc is not required, unless the condition of the disc warrants its removal.
A posterior procedure for implanting the assembly of implant structures 20 shown in
The intimate contact created between the bony in-growth or through-growth region 24 along the surface of the implant structure 20 across the facet joint accelerates bony in-growth or through-growth onto, into, or through the implant structure 20, to accelerate fusion of the facets joints between L4 and L5. Of course, translaminar lumbar fusion between L5 and S1 can be achieved using first and second implant structures in the same manner.
As can be seen in the representative embodiment illustrated in
A posterior procedure for implanting the assembly of implant structures 20 shown in
The intimate contact created between the bony in-growth or through-growth region 24 along the surface of the implant structure 20 across the facet joint accelerates bony in-growth or through-growth onto, into, or through the implant structure 20, to accelerate fusion of the facets joints between L4 and L5.
Of course, transfacet lumbar fusion between L5 and S1 can be achieved using first and second implant structures in the same manner.
As
The posterolateral approach involves less soft tissue disruption than the lateral approach, because there is less soft tissue overlying the entry point of the posterior iliac spine of the ilium. Introduction of the implant structure 20 from this region therefore makes possible a smaller, more mobile incision.
The set-up for a posterolateral approach is generally the same as for a lateral approach. It desirably involves the identification of the lumbar region that is to be fixated or fused (arthrodesed) using, e.g., the Faber Test, or CT-guided injection, or X-ray/MRI of the L5-S1 level. It is desirable performed with the patient lying in a prone position (on their stomach) and is aided by lateral and anterior-posterior (A-P) c-arms. The same surgical tools are used to form the pilot bore over a guide pin (e.g., on the right side), except the path of the pilot bore now starts from the posterior iliac spine of the ilium, angles through the SI-Joint, and terminates in the lumbar vertebra L5. The broached bore is formed, and the right implant 20 structure is inserted. The guide pin is withdrawn, and the procedure is repeated for the left implant structure 20, or vice versa. The incision site(s) are closed.
The assembly as described makes possible the achievement of trans-iliac lumbar fusion using a posterolateral approach in a non-invasive manner, with minimal incision, and without necessarily removing the intervertebral disc between L5 and S1.
As shown, the implant structure 20 extends from a posterolateral region of the sacral vertebra S1, across the intervertebral disc into an opposite anterolateral region of the lumbar vertebra L5. The implant structure 20 extends in an angled path (e.g., about 20 degrees to about 40 degrees off horizontal) through the sacral vertebra S1 in a superior direction, through the adjoining intervertebral disc, and terminates in the lumbar vertebra L5.
A physician can employ a posterior approach for implanting the implant structure 20 shown in
The physician can, if desired, combine stabilization of the spondylolisthesis, as shown in
In addition, in some embodiments as shown in
Any of the implants herein, including any of the composite implants herein, may be implanted based on the general illustration in
In some implementations, just one implant is placed across each SI-joint using an S2AI trajectory, as depicted in
It should be noted that, according to aspects of the present disclosure, a tulip, saddle structure, poly-axial joint, fastening mechanism or other coupling device (such as shown in
In this embodiment, body portion 2504 is provided with a central lumen 2514 configured to slide over the proximal end of shank portion 2502. Radially outward extending splines 2516 may be provided at one or more locations on shank portion 2502, as best seen in
In this embodiment, body portion 2504 has a triangular cross-section to prevent it from rotating relative to surrounding bone. When body portion 2504 is placed across a joint or fracture between two bone segments as previously described, body portion 2504 inhibits the two bone segments from rotating or translating relative to one another. In other embodiments (not shown), the body portion may have a square, rectangular, oval or other cross-sectional shape with at least one rectilinear face and/or at least one apex to similarly prevent rotation. When body portion 2504 is prevented from rotating relative to the surrounding bone by virtue of its non-rotationally shaped cross-section, and when splines 2516 prevent shank portion 2502 from rotating relative to body portion 2504, shank portion 2502 is prevented from rotating relative to the surrounding bone. This arrangement prevents shank portion 2502 from undesirably backing out or migrating further into the bone.
Body portion 2504 may be provided with fenestrations 2518 to allow for bony on-growth, in-growth and through-growth. In this exemplary embodiment, a repeating pattern of spars and cross-struts creates a plurality of triangularly shaped fenestrations on each face of body portion 2504. Each of the fenestrations 2518 opens into the central lumen 2514 of body portion 2504. In some embodiments, body portion 2504 is fabricated using an additive manufacturing process such as 3D printing. Further information on designing and manufacturing fenestrated implants is provided in the applicant's U.S. Pat. No. 9,662,157, filed Sep. 18, 2015, and titled “Matrix Implant.” The distal end of body portion 2504 may also be provided with tapered and rounded leading edges 2520 as shown to facilitate inserting body portion 2504 into one or more bone segments. Trailing edges 2522 having a lesser degree of taper may be provided on the proximal end of body portion 2504 as shown to facilitate removal of body portion 2504 from the bone, if desired. Having less taper on trailing edges 2522 permits better engagement between the proximal end and surrounding cortical bone surfaces.
Head portion 2506 may be provided with a coupler 2524 and a main body 2526 as shown in
Referring to
In some embodiments, as shown in
y=(F·x2)/(6·E·I)(x−3·l)
I=(D4−d4)π/64
In some embodiments, as shown in
Implant 2500/2500′ may be installed in bone, such as across a bone joint or fracture, in a manner similar to that previously described relative to
In embodiments having a separate head portion that is assembled to a shank portion during implantation as described above, a variety of different head portions can be provided in a kit without having to provide the entire implant for each head type. For example, head portions can be provided that couple to a 5.0, 5.5, 6.0, or 6.35 mm diameter rod. Shank portions and body portions may also be provided in various lengths, widths and or shapes. With this modular approach, a specific head type may be assembled to a specific shank portion and body portion to create a greater number of combinations without having to stock a separate implant for each combination.
In some embodiments, shank portion 2502 can be installed in the bone, and then a broach can be inserted over the proximal end of installed shank portion 2502 to create a shaped bore. After the broach is removed, body portion 2504 may then be installed over shank portion 2502. In some embodiments, the body portion may include an integrated broach such that the body portion can be installed without first preparing a shaped bore in the bone. In some embodiments, body portion 2504 can be installed in the bone first, and then shank portion 2502 can be installed into the bone through body portion 2504, with or without head portion 2506 attached to shank portion 2502 as it is being installed.
According to aspects of the present disclosure, the arrangement of the current embodiment allows for one portion of an implant to be screwed into place, another portion to be tapped into place, and the two portions locked together to take advantage of the anti-rotational aspects of the tapped in portion. In embodiments without splines or other locking features, the various portions can be implanted separately as previously described, or the assembled implant can be installed as a single unit with the body portion rotating in a shaped bore in the bone as the shank portion is screwed into place. In other embodiments having releasable locking features (not shown), the assembled implant can be installed as a single unit with the locking feature released, allowing the shank portion to rotate relative to the body portion. After the implant is installed, the locking feature can be engaged to prevent rotation.
The proximal end of body portion 2604 may be provided with a flat surface (not shown) to allow shank portion 2602 and body portion 2604 to be tapped into place together into the bone segment(s). Alternatively, internal threads (not shown) may be provided to allow a slap-hammer or other insertion instrument to be temporarily attached to the proximal end of body portion 2604 to aid in inserting implant 2600. A central lumen 2612 may be provided along the longitudinal axis of shank portion 2602 and body portion 2604 to allow them to be placed over a guidewire or guide pin when being implanted.
In this embodiment, body portion 2604 has a triangular cross-section to prevent it from rotating relative to surrounding bone. When body portion 2604 is placed across a joint or fracture between two bone segments as previously described, body portion 2604 inhibits the two bone segments from rotating relative to one another. In other embodiments (not shown), the body portion may have a square, rectangular, oval or other cross-sectional shape with at least one rectilinear face and/or at least one apex to similarly prevent rotation.
Body portion 2604 may be provided with fenestrations 2618 to allow for bony on-growth, in-growth and through-growth. In this exemplary embodiment, a repeating pattern of alternating triangularly shaped fenestrations may be provided on each face of body portion 2604. Each of the fenestrations 2618 opens into a central lumen of body portion 2604. In some embodiments, body portion 2604 is fabricated using an additive manufacturing process such as 3D printing. Further information on designing and manufacturing fenestrated implants is provided in the applicant's U.S. Pat. No. 9,662,157, filed Sep. 18, 2015, and titled “Matrix Implant.” The distal end of body portion 2604 may also be provided with tapered leading edges 2620 as shown to facilitate inserting body portion 2604 into one or more bone segments. Trailing edges 2622 having a lesser degree of taper may be provided on the proximal end of body portion 2604 as shown to facilitate removal of body portion 2604 from the bone, if desired. Having less taper on trailing edges 2622 permits better engagement between the proximal end and surrounding cortical bone surfaces.
Head portion 2606 may be provided with a coupler 2624 and a main body 2626 as shown in
Implant 2600 may be installed in bone, such as across a bone joint or fracture, in a manner similar to that previously described relative to
Body portion 2704 includes a porous exterior surface that is configured to reside across a bone joint and/or a proximal bone segment when implanted. In this embodiment, body portion 2704 includes a radially inward portion 2708 that is solid and a radially outward portion 2710 that is a porous bony in-growth region, as shown in
Implant 2700 can be made of a variety of materials. For example, the implant can be made of a metal or metal alloy, such as titanium or steel, or a nonmetallic material such as ceramic or polymer. In some embodiments, the implant material can have a certain lattice microstructure formed from microparticles. For example, the lattice microstructure can result in a rough or smooth surface texture, depending on the surface finishing techniques used, such as polishing or application of a metal plasma spray. A 3-D printing process may be used to fabricate some or all of implant 2700, which allows the porosity of the implant or printed portions to be controlled. For example, the implant can have a volume porosity between about 30 and 70 percent, with an average pore size between 100 and 1000 microns. The pores can be largely interconnected, largely unconnected, or a mix of interconnected and unconnected pores. In some embodiments, the pores can be located throughout the material of the implant, including the inner and outer implant surfaces. For example, the fusion of the microparticles that form the implant can result in a porous, semi-porous, or nonporous structure, depending on the degree of fusion between the microparticles. In other embodiments, the pores can be located in a porous coating that can be applied onto the implant. For example, a porous coating can be applied using a titanium plasma spray process, or another metal plasma spray process. The coating can be applied to the outer surfaces of the implant, the interior surfaces of the implant, or both the outer and interior surfaces of the implant. For example, the coating could be preferentially applied to the outer surface of a matrixed implant to provide bony ingrowth and on-growth, and not applied to the inner portion of the implant to maximize bony through-growth within the implant. Also, the coating can be applied preferentially from proximal to distal, or vice versa. The thickness of a porous coating can be between about 500 and 1,500 microns. In addition or alternatively to the porous metal coating, a hydroxyapatite coating can also be applied to the implant. In some embodiments, the porosity can be varied along the length of the implant. In some embodiments, the thickness of the coating can be varied along the length of the implant. In some embodiments, the thickness of the coating applied to the outer surface can be different than the thickness of the inner coating. For example, the outer coating may be greater than the inner coating in some embodiments. In other embodiments, the thickness of the inner and outer coatings can be the same.
Body portion 2804 includes a porous exterior surface that is configured to reside across a bone joint and/or a proximal bone segment when implanted, and may be similar to body portion 2704 previously described in reference to
Body portion 2904 includes a porous exterior surface that is configured to reside across a bone joint and/or a proximal bone segment when implanted, and may be similar to body portion 2704 previously described in reference to
Body portion 3004 includes a porous exterior surface that is configured to reside across a bone joint and/or a proximal bone segment when implanted, and may be similar to body portion 2704 previously described in reference to
The embodiment in
As in the embodiments above, proximal region 3104 is adapted to facilitate at least one of bony on-growth, in-growth, or through-growth. In this example, the adaption includes a porous surface 3114, which is formed in between one or more threads. The thread 3112 in the central region of the proximal region is discontinuous, but has an overall helical configuration. The proximal region 3104 includes a plurality of fenestrations 3113 (which are larger than the pores 3114), a subset of which together are disposed in at least a partial helical configuration, as shown in the figure. In this embodiment multiple subsets of the plurality of fenestrations 3113 are each disposed in a partial helical configuration. At least some of the fenestrations are disposed at the location of the thread discontinuities, as shown in the figure.
Implant 3100 includes inner elongate body 3108 and outer elongate body 3106. Inner and outer elongate bodies are adapted to stably interface with one another to resist relative motion in at least one direction. Inner elongate body 3108 includes the thread 3110 on the distal region 3102 of the implant. Outer elongate body 3106 includes the thread 3112 on the proximal region 3104 of the implant. Inner elongate body 3108 has a proximal region 3111 that is non-threaded, which optionally may include a thread that interfaces with an optional internal thread on outer body 3106. Outer body includes a distal region 3107 that includes a dual-lead thread, a central region with a single lead thread, and a proximal dual-thread region 3109. One of the threads from distal region 3107 does not continue into the central region with the single thread. Outer body 3106 also includes relatively large fenestrations 3113, as well as relatively smaller pores 3114 that are in between the threads. Outer elongate body 3106 has a larger outer diameter than inner elongate member 3108. Outer elongate body 3106 can have an inner diameter radially spaced from the outer diameter of the inner elongate body 3108, thereby creating a volume of space radially between the inner and outer elongate bodies 3106 and 3108.
In this exemplary embodiment the inner and outer bodies each have one or more features that allow them to be engaged such that relative movement between the two is resisted in at least one direction, optionally resisting rotation. Outer body 3106 includes one or more surface feature 3121 disposed at a distal end region of the outer body 3106 sized and configured to interface with a protruding feature (optionally linear) on inner elongate body 3108, the interface of which prevents rotation between the outer and inner elongate bodies. In this embodiment rotation is prevented at the distal end of the outer elongate body due to the interfacing features. A wide variety of features can be incorporated onto the inner and outer elongate bodies to provide this functionality, such as that shown and described with reference to
When implants herein are implanted in a SAI trajectory (e.g. S2AI) for positioning across an SI joint (details of which are described elsewhere herein), a portion of the implant that has one or more surface features specifically adapted to facilitate at least one of bony on-growth, in-growth, or through-growth should be positioned at the location of the SI joint.
With respect to
Implant ingrowth region 3304 includes a plurality of fenestrations 3306 and smaller pores 3305, both of which extend through an outer surface and an inner surface of the proximal region, creating a passageway from an inner implant volume (but not the “innermost” volume in this embodiment) to a location outside the implant. Fenestrations 3306 and pores 3305 help adapt the proximal anchoring region to facilitate in-growth.
In this embodiment, implant 3300 includes inner component 3320 (e.g., a screw or screw-like component) and outer component 3340 (e.g., an outer sleeve), which are adapted to be secured relative to one another prior to the implant being fully implanted (e.g. secured prior to any part of the implant being implanted, or secured at some point during the procedure), and which are not integrally formed from the same component. The inner component is an example of an inner shank, and the outer component is an example of a sleeve. Inner component 3320 and outer component 3340 are shown individually, not secured together, in
The plurality of sets of fenestrations 3306 in this embodiment are configured and oriented so that a physician can see passing through the outer component from one side to the other using radiographic imaging to monitor bony ingrowth and fusion over time.
An exemplary advantage of having a composite implant with two (or more) pieces is that a first (e.g. inner shank) component that is more resistant to fatigue can be manufactured using some common techniques, which may include some common screw manufacturing techniques. The first component (e.g. inner component) may be made from a material that is relatively more resistant to fatigue, such as, for example without limitation, titanium or stainless steel. For example, inner component 3320 shown in
Any of the composite implants in this disclosure may thus benefit from the exemplary advantages of composite implants set forth herein.
As set forth herein, the implants in
Other types of implants that may appear to have similar structure and dimensions many not necessary provide the advantages set forth herein. For example, the relative lengths of different sections of the those other implants, in combination with the overall length of those implants, may not necessary be sized to provide the benefits herein when implanted according to methods set herein. For example, other types of implants may not have a distal anchoring section that is sized (including length) and configured for ilium bone anchoring, and a proximal section that is sized (including length) to be positioned across a SI joint when the distal anchoring region is disposed in the ilium, the proximal region adapted to facilitate tissue growth.
The distal anchoring regions (e.g. region 3302 in
In some embodiments the length of the distal region is from 10 mm to 80 mm, such as from 10 mm to 60 mm, such as from 10 mm to 50 mm, such as from 10 mm to 40 mm, such as from 10 mm to 40 mm, such as 15 mm to 35 mm, such as 20 mm to 30 mm.
The proximal region may be longer than the distal region, such as in the embodiments in
In some embodiments the proximal growth region is longer than the distal anchoring region, and in some embodiments is 1-3 times the length of the distal anchoring region, such as 1.1 times-2.9 times the length of the distal anchoring region. For example, in the embodiment in
The distal anchoring region (e.g. region 3302, 3102) may be a double lead threaded region, such as the embodiment in
In the embodiment in
In some merely exemplary embodiments, outer component 3340 (e.g. outer sleeve) can have a thread (e.g. 3103) that has a pitch that may be constant along most of its length, as is the case in
The outer component in
As set forth herein, the internal surface of the outer component 3340 can have an internal threaded region, which is configured to interface with external threaded region 3321 (see
In some embodiments the outer and inner components are adapted such that when assembled the outer component is put under compression due to the secured engagement between the two components. Components in bending may fail on the surface that is exposed to tension, so pre-stressing one or more components in compression can provide the benefit a higher working load range. Pre-stressing the outer component is, however, optional. Any of the implants herein can be pre-stressed in this manner to provide the benefit of a higher working load range.
With any of the implants herein, the distal end (or proximal end) of the outer component can be secured to the inner component while the proximal end (or distal end) is not secured to resist relative movement in at least one direction. By allowing the proximal end (or distal end) to be freely moveable relative to the inner component, the implant may beneficially be less likely to fatigue, due to fewer forces acting on the implant.
In alternative embodiments, the shaft region of the inner component (e.g. 3322 in
It is understood that any suitable feature described with respect to any of the implants in
Even if not specifically described, the implants disclosed in
Any of the exemplary features in any of the composite implants herein may be integrated or incorporated into other composite implant examples herein, unless specifically indicated to the contrary.
In this embodiment, sleeve 3410 is configured such that it can be front loaded over the shank 3430. That is, the distal end of the shank can be advanced into the proximal end of the sleeve (relative motion) to assemble the shank and sleeve into the assembled configuration shown in
Sleeve 3410 includes a tapered distal threaded region 3411, any portion of which may be textured. In this embodiment tapered distal threaded region 3411 is a dual lead thread. Sleeve 3410 also includes central region 3412, which includes a single lead as shown, a plurality of fenestrations 3413, and a plurality of discrete lattice sections 3414 (only one labeled). In this example, each of (in other embodiments at least some of) the plurality of fenestrations 3413 is disposed between axially adjacent thread regions, as shown. In this example each of (in other embodiments at least some of) the plurality of lattice sections 3413 is disposed between axially adjacent thread regions, as shown. In this example multiple subsets of the plurality of fenestrations are each disposed to a partial helical configuration, as shown. In this example multiple subsets of the plurality of lattice sections are each disposed to a partial helical configuration, as shown.
Implant 3400 includes a distal anchoring region (“DAR” in
The sleeve in
In any of the composite implant examples herein, the sleeves may be manufactured by printing.
The shank includes a section 3551 and a section 3552, with section 3553 axially in between. Either or both of sections 3551 and 3552 may be textured, such as with TPS, grit blast, HA, for example without limitation, to facilitate one or more of in growth, on-growth, or through growth. Section 3553 can include a central thread as shown. The thread in central section 3553 may be made with the same thread pass as the pass creating the threads on the distal shank section. A benefit of the thread in central section 3553 can be that it creates volume between the sleeve and shank that can increase graft volume while providing support to the sleeve.
Any of the inner members herein, such as any shank herein, can be manufactured by machining the inner member. In some embodiments the inner member can be machined out of a solid material such as titanium. The central rib in section 3553 is an example of a central rib that can be configured to reduce the bending moment on the shank. This can be helpful for relatively longer shank lengths, such as 80-120 mm length shanks.
Any of the shanks herein (one any section thereof) may have one or more holes therethrough, such as to facilitate post-implant administering one or more agents (e.g. PMMA into the ilium).
In any of the examples herein, the sleeve apertures herein may have one angled edge to help cut bone while screwing the implant into position, and the other edge can be straight, as shown in the examples in
The implant may have one or more ways in which the sleeve interacts with the shank to help stabilize the sleeve relative to the shank when assembled. For example, the shank can have a shank interface feature and the sleeve can have a sleeve interface feature that are configured to interface with each other so as to resist relative motion between the sleeve and the inner shank in at least one direction (e.g. axial, radial, rotational). For example, the sleeve and shank may interface in one or both of a distal anchoring region and a proximal region of the implant to help stabilize the sleeve relative to the shank. In some examples the shank and sleeve do not interface in a central region of the implant.
For example, the shank 4230 may include, in the distal threaded region, a detent, depression, or barb 4239 in a thread, as shown in
The sleeve and the shank may alternatively or in addition to interface in a proximal end region of the composite implant to resist relative movement therebetween in at least one direction.
Alternatively or in addition to, the shank/sleeve interface can include a tapered locking connection in tapered locking connection region 4460. At this interface region the shank and sleeve can include distal tapers as shown, which together form a taper lock.
Alternatively or in addition to, the shank/sleeve interface can include a proximal end region interface in region 4470, which in this embodiment includes a tight sliding fit between optionally smooth surface of the sleeve and shank. The surface 4419 of the shank that sleeve interfaces with is shown in
In any of the embodiments herein, the sleeve and shank can interface in a distal region, such as in one or both of regions 4450 and/or 4460 in
Additionally, if the sleeve and shank interface in a proximal region, the proximal interface region may provide for some relative movement between the sleeve and shank, but can still provide some degree of overall resistance to movement therebetween in at least one direction.
Implant 4500 is an example of a composite implant in which the sleeve can be placed under compression upon assembly of the shank, for exemplary benefits set forth herein. For example, components in bending may fail on the surface that is exposed to tension, so pre-stressing one or more components in compression can provide the benefit of a higher working load range. Pre-stressing the outer component is, however, optional. Any of the implants herein can be pre-stressed in this manner to provide the benefit of a higher working load range. Implant 4500 includes shank 4530 that includes stop 4539 in the configuration of a shoulder, as shown. The stop 4339 provides a mechanical stop for sleeve 4510 and help compress the sleeve (pre-strain), for reasons set forth herein. One separate aspect of this disclosure is thus a composite implant wherein an outer member (e.g. sleeve) is put under compression when interfaced with an inner member (e.g. shank). One of the optional benefits of pre-straining/pre-compressing the sleeve would be in cases where the sleeve might or would be more likely to break before the shank due to material properties of the sleeve compared to the shank.
In some embodiments, a distal anchoring region (“DAR” in
In some embodiments, a growth region (e.g. “GR” in
In some embodiments, a proximal anchoring region (e.g. “PAR” in
In some embodiments, an overall screw length of the implant (such as a composite implant), which may a combination of DAR, GR, and PAR, in some embodiments, may be from 60 mm-100 mm, such as 65 mm to 95 mm, such as 70 mm, to 90 mm, such as 75 mm to 85 mm, such as 80 mm.
In some embodiments, an overall implant length (such as a composite implant), which may a combination of DAR, GR, optional PAR, and proximal coupling region 4760, may be from 65 mm-110 mm, such as 70 mm to 105 mm, such as 75 mm, to 100 mm, such as 80 mm to 95 mm, such as 85 mm.
With reference to
One aspect of this disclosure is related to bone stabilizing implant that includes one or more deployable members, the one or more deployable members having non-deployed configurations and a deployed configuration.
Exemplary methods of implanting implant 4800 can include one or more of following steps, and may not necessary be in the order that follows. During implant insertion, the deployable members 4804, 4804′, 4804″ are in non-deployed (e.g. recessed) positions relative to implant body 4802. The implant can be threaded into bone similar to a screw. After the implant is located in a target location, the deployable members can be deployed by actuating the inner actuation member, such as by rotating the inner actuating member, which may include one or more camming surfaces. The deployed member (e.g., 4804) are configured, once deployed, to aid in preventing joint rotation, thereby increasing the stability of the joint. The elongate body 4804, which can include any features of any sleeve herein, can include one or more growth features (e.g., fenestrations, lattice sections) to facilitate one or more of bony on-growth, in-growth, or through-growth.
Implant 4800 is an example of an implant with an elongate implant body that includes one or more threads, optionally a plurality of regions having different number of leads.
Implant 4800 is an example of an implant with an elongate body (e.g. 4802) that includes a plurality of rows of openings (optionally linear rows), each of the rows including a plurality of openings separated by a portion of the elongate implant body.
Implant 4800 is an example of an implant with an elongate implant body that separates a plurality of openings, wherein the separating portion includes one or more threads.
Implant 4800 is an example of an implant with deployable members, wherein any of the deployable members include a plurality of protrusions extending from a spine, the protrusions extending further radially outward than the spine, and optionally the protrusions formed integrally with the spine.
Implant 4800 is an example of an implant with one or more deployable members that are positioned relative to an elongate implant body 4802 such that they are deployed upon actuation of an internal deployment member.
Implant 4800 is an example of an implant wherein an internal deployment member comprises a plurality of radially protruding camming surfaces that when rotated cause one or more deployable members to move radially outward.
Implant 4800 is an example of an implant with one or more threads on an elongate implant body, wherein the threads provide a mechanical radial stop to one or more deployable members, optionally preventing the opening(s) from bowing under load.
Implant 4800 is an example of an implant with an implant body with openings that can be tapered to limit play between the elongate implant body and the one or more deployable members.
Implant 4800 is an example of an implant with an elongate implant body that can have one or more porous surfaces.
Implant 4800 is an example of an implant with a plurality of deployable members that can be actuated and deployed by an inner actuatable member.
Any of the composite implants herein can include a volume defined by an inner surface of the sleeve and an outer surface of the shank. That is, a gap can exist between the outer surface of the shank and the inner surface of the sleeve. The volume can facilitate bony ingrowth.
As set forth above, when the composite implants herein are advanced via a posterior sacral alar-iliac (“SAI”) trajectory and disposed across an SI joint, it can be advantageous when certain regions of the implant are adjacent certain bone or tissue once fully implanted. As set forth above, the distal region of the implant is generally configured to be able to better anchor into relatively denser cortical bone, such as with a dual threaded distal region. With some of the composite implants above (e.g.
In some methods of use, the implants herein (e.g. the composite implants) as delivered with a posterior sacral alar-iliac (“SAI”) trajectory. Without intending to be limiting, there can be benefits to implanting any of the composite implants herein such that at least 15 mm of the implant extends distal to the SI joint in the final implanted position. In some methods of use the implants extend at least 15 mm-20 mm beyond the SI joint. The distal anchoring region thus can have lengths that facilitate a distal anchoring region of the implant extending at least 15 mm beyond the joint. This can help ensure the implant distal anchoring region extends into the dense cortical ilium bone and helps anchor the implant.
Any of the sleeves herein include an inner lumen, the inner lumen sized and configured to receive at least a portion of an inner member (e.g. inner shank).
Variations and modifications of the devices and methods disclosed herein will be readily apparent to persons skilled in the art. As such, it should be understood that the foregoing detailed description and the accompanying illustrations, are made for purposes of clarity and understanding, and are not intended to limit the scope of the invention, which is defined by the claims appended hereto. Any feature described in any one embodiment described herein can be combined with any other feature of any of the other embodiment whether preferred or not.
It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and scope of the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference for all purposes.
This application is a continuation of International Application No. PCT/US2020/018402, filed Feb. 14, 2020, which claims the benefit of priority to U.S. application Ser. No. 16/276,430, filed Feb. 14, 2019, U.S. Prov. App. 62/859,646, filed Jun. 10, 2019, and to U.S. Prov. App. 62/933,250, filed Nov. 8, 2019, the disclosures of which are incorporated by reference herein for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
1951278 | Ericsson | Mar 1934 | A |
2136471 | Schneider | Nov 1938 | A |
2243717 | Moreira | May 1941 | A |
2414882 | Longfellow | Jul 1947 | A |
2562419 | Ferris | Jul 1951 | A |
2675801 | Bambara et al. | Apr 1954 | A |
2697433 | Zehnder | Dec 1954 | A |
3076453 | Tronzo | Feb 1963 | A |
3506982 | Steffee | Apr 1970 | A |
3694821 | Moritz | Oct 1972 | A |
3709218 | Halloran | Jan 1973 | A |
3744488 | Cox | Jul 1973 | A |
4059115 | Jumashev et al. | Nov 1977 | A |
4156943 | Collier | Jun 1979 | A |
4292964 | Ulrich | Oct 1981 | A |
4341206 | Perrett et al. | Jul 1982 | A |
4344190 | Lee et al. | Aug 1982 | A |
4399813 | Barber | Aug 1983 | A |
4423721 | Otte et al. | Jan 1984 | A |
4475545 | Ender | Oct 1984 | A |
4501269 | Bagby | Feb 1985 | A |
4569338 | Edwards | Feb 1986 | A |
4612918 | Slocum | Sep 1986 | A |
4622959 | Marcus | Nov 1986 | A |
4630601 | Harder et al. | Dec 1986 | A |
4638799 | Moore | Jan 1987 | A |
4657550 | Daher | Apr 1987 | A |
4743256 | Brantigan | May 1988 | A |
4773402 | Asher et al. | Sep 1988 | A |
4787378 | Sodhi | Nov 1988 | A |
4790303 | Steffee | Dec 1988 | A |
4834757 | Brantigan | May 1989 | A |
4846162 | Moehrirg | Jul 1989 | A |
4877019 | Vives | Oct 1989 | A |
4878915 | Brantigan | Nov 1989 | A |
4898186 | Ikada et al. | Feb 1990 | A |
4904261 | Dove et al. | Feb 1990 | A |
4950270 | Bowman et al. | Aug 1990 | A |
4961740 | Ray et al. | Oct 1990 | A |
4969888 | Scholten et al. | Nov 1990 | A |
4981481 | Kranz et al. | Jan 1991 | A |
5034011 | Howland | Jul 1991 | A |
5034013 | Kyle et al. | Jul 1991 | A |
5035697 | Frigg | Jul 1991 | A |
5041118 | Wasilewski | Aug 1991 | A |
5053035 | McLaren | Oct 1991 | A |
5059193 | Kuslich | Oct 1991 | A |
5066296 | Chapman et al. | Nov 1991 | A |
5098434 | Serbousek | Mar 1992 | A |
5102414 | Kirsch | Apr 1992 | A |
5108397 | White | Apr 1992 | A |
5122141 | Simpson et al. | Jun 1992 | A |
5139498 | Astudillo Ley | Aug 1992 | A |
5139500 | Schwartz | Aug 1992 | A |
5147367 | Ellis | Sep 1992 | A |
5147402 | Bohler et al. | Sep 1992 | A |
5190551 | Chin et al. | Mar 1993 | A |
5197961 | Castle | Mar 1993 | A |
5242444 | MacMillan | Sep 1993 | A |
5298254 | Prewett et al. | Mar 1994 | A |
5334205 | Cain | Aug 1994 | A |
5380325 | Lahille et al. | Jan 1995 | A |
5390683 | Pisharodi | Feb 1995 | A |
5433718 | Brinker | Jul 1995 | A |
5443466 | Shah | Aug 1995 | A |
5458638 | Kuslich et al. | Oct 1995 | A |
5470334 | Ross et al. | Nov 1995 | A |
5480402 | Kim | Jan 1996 | A |
5569249 | James et al. | Oct 1996 | A |
5591235 | Kuslich | Jan 1997 | A |
5593409 | Michelson | Jan 1997 | A |
5607424 | Tropiano | Mar 1997 | A |
5609635 | Michelson | Mar 1997 | A |
5609636 | Kohrs et al. | Mar 1997 | A |
5626616 | Speece | May 1997 | A |
5643264 | Sherman et al. | Jul 1997 | A |
5645599 | Samani | Jul 1997 | A |
5658337 | Kohrs et al. | Aug 1997 | A |
5667510 | Combs | Sep 1997 | A |
5669909 | Zdeblick et al. | Sep 1997 | A |
5672178 | Petersen | Sep 1997 | A |
5683391 | Boyd | Nov 1997 | A |
5709683 | Bagby | Jan 1998 | A |
5713904 | Errico et al. | Feb 1998 | A |
5716358 | Ochoa et al. | Feb 1998 | A |
5725581 | Brånemark | Mar 1998 | A |
5743912 | LaHille et al. | Apr 1998 | A |
5759035 | Ricci | Jun 1998 | A |
5766174 | Perry | Jun 1998 | A |
5766252 | Henry et al. | Jun 1998 | A |
5766261 | Neal et al. | Jun 1998 | A |
5788699 | Bobst et al. | Aug 1998 | A |
5800440 | Stead | Sep 1998 | A |
5868749 | Reed | Feb 1999 | A |
5897556 | Drewry et al. | Apr 1999 | A |
5928239 | Mirza | Jul 1999 | A |
5941885 | Jackson | Aug 1999 | A |
5961522 | Mehdizadeh | Oct 1999 | A |
5961554 | Janson et al. | Oct 1999 | A |
6010507 | Rudloff | Jan 2000 | A |
6015409 | Jackson | Jan 2000 | A |
6030162 | Huebner et al. | Feb 2000 | A |
6053916 | Moore | Apr 2000 | A |
6056749 | Kuslich | May 2000 | A |
6066175 | Henderson et al. | May 2000 | A |
6086589 | Kuslich et al. | Jul 2000 | A |
6096080 | Nicholson et al. | Aug 2000 | A |
6120292 | Buser et al. | Sep 2000 | A |
6120504 | Brumback et al. | Sep 2000 | A |
6143031 | Knothe et al. | Nov 2000 | A |
6197062 | Fenlin | Mar 2001 | B1 |
6206924 | Timm | Mar 2001 | B1 |
6210442 | Wing et al. | Apr 2001 | B1 |
6214049 | Gayer et al. | Apr 2001 | B1 |
6221074 | Cole et al. | Apr 2001 | B1 |
6224607 | Michelson | May 2001 | B1 |
6241732 | Overaker et al. | Jun 2001 | B1 |
6264657 | Urbahns et al. | Jul 2001 | B1 |
6270528 | McKay | Aug 2001 | B1 |
6287343 | Kuslich et al. | Sep 2001 | B1 |
6302885 | Essiger | Oct 2001 | B1 |
6302914 | Michelson | Oct 2001 | B1 |
6306140 | Siddiqui | Oct 2001 | B1 |
6319253 | Ackeret et al. | Nov 2001 | B1 |
6406498 | Tormala et al. | Jun 2002 | B1 |
6409768 | Tepic et al. | Jun 2002 | B1 |
6451020 | Zucherman et al. | Sep 2002 | B1 |
6471707 | Miller et al. | Oct 2002 | B1 |
6485518 | Cornwall et al. | Nov 2002 | B1 |
6497707 | Bowman et al. | Dec 2002 | B1 |
6517541 | Sesic | Feb 2003 | B1 |
6520969 | Lambrecht et al. | Feb 2003 | B2 |
6524314 | Dean et al. | Feb 2003 | B1 |
6527775 | Warburton | Mar 2003 | B1 |
6556857 | Estes et al. | Apr 2003 | B1 |
6558386 | Cragg | May 2003 | B1 |
6565566 | Wagner et al. | May 2003 | B1 |
6575899 | Foley et al. | Jun 2003 | B1 |
6575991 | Chesbrough et al. | Jun 2003 | B1 |
6579293 | Chandran | Jun 2003 | B1 |
6582431 | Ray | Jun 2003 | B1 |
6582467 | Teitelbaum et al. | Jun 2003 | B1 |
6595998 | Johnson et al. | Jul 2003 | B2 |
6602293 | Biermann et al. | Aug 2003 | B1 |
6605090 | Trieu et al. | Aug 2003 | B1 |
6607530 | Carl et al. | Aug 2003 | B1 |
6620163 | Michelson | Sep 2003 | B1 |
6635059 | Randall et al. | Oct 2003 | B2 |
6666868 | Fallin | Dec 2003 | B2 |
6669529 | Scaries | Dec 2003 | B1 |
6673075 | Santilli | Jan 2004 | B2 |
6692501 | Michelson | Feb 2004 | B2 |
6712852 | Chung et al. | Mar 2004 | B1 |
6723099 | Goshert | Apr 2004 | B1 |
6723100 | Biedermann et al. | Apr 2004 | B2 |
6740118 | Eisermann et al. | May 2004 | B2 |
6743257 | Castro | Jun 2004 | B2 |
D493533 | Blain | Jul 2004 | S |
6793656 | Mathews | Sep 2004 | B1 |
6827740 | Michelson | Dec 2004 | B1 |
6984235 | Huebner | Jan 2006 | B2 |
6989033 | Schmidt | Jan 2006 | B1 |
6991461 | Gittleman | Jan 2006 | B2 |
6993406 | Cesarano et al. | Jan 2006 | B1 |
7018416 | Hanson et al. | Mar 2006 | B2 |
7118579 | Michelson | Oct 2006 | B2 |
7147666 | Grisoni | Dec 2006 | B1 |
7175663 | Stone | Feb 2007 | B1 |
7211085 | Michelson | May 2007 | B2 |
7223269 | Chappuls | May 2007 | B2 |
7314488 | Relley | Jan 2008 | B2 |
7335205 | Aeschlimann et al. | Feb 2008 | B2 |
7338500 | Chappuis | Mar 2008 | B2 |
7396365 | Michelson | Jul 2008 | B2 |
7452359 | Michelson | Nov 2008 | B1 |
7452369 | Barry | Nov 2008 | B2 |
7481831 | Bonuti | Jan 2009 | B2 |
7527649 | Blain | May 2009 | B1 |
7534254 | Michelson | May 2009 | B1 |
7537616 | Branch et al. | May 2009 | B1 |
7569054 | Michelson | Aug 2009 | B2 |
7569059 | Cerundolo | Aug 2009 | B2 |
7601155 | Petersen | Oct 2009 | B2 |
7608097 | Kyle | Oct 2009 | B2 |
7648509 | Stark | Jan 2010 | B2 |
7686805 | Michelson | Mar 2010 | B2 |
7699852 | Frankel et al. | Apr 2010 | B2 |
7708761 | Petersen | May 2010 | B2 |
7727235 | Contiliano et al. | Jun 2010 | B2 |
7758646 | Khandkar et al. | Jul 2010 | B2 |
7780704 | Markworth et al. | Aug 2010 | B2 |
7846162 | Nelson et al. | Dec 2010 | B2 |
7850732 | Heinz | Dec 2010 | B2 |
7857832 | Culbert et al. | Dec 2010 | B2 |
7887565 | Michelson | Feb 2011 | B2 |
7892265 | Perez-Cruet et al. | Feb 2011 | B2 |
7901439 | Horton | Mar 2011 | B2 |
7909832 | Michelson | Mar 2011 | B2 |
7922765 | Reiley | Apr 2011 | B2 |
7942879 | Christie et al. | May 2011 | B2 |
8052728 | Hestad | Nov 2011 | B2 |
8062365 | Schwab | Nov 2011 | B2 |
8066705 | Michelson | Nov 2011 | B2 |
8066709 | Michelson | Nov 2011 | B2 |
8142481 | Warnick | Mar 2012 | B2 |
8202305 | Reiley | Jun 2012 | B2 |
8268099 | O'Neill et al. | Sep 2012 | B2 |
8308779 | Reiley | Nov 2012 | B2 |
8308783 | Morris et al. | Nov 2012 | B2 |
8317862 | Troger et al. | Nov 2012 | B2 |
8348950 | Assell et al. | Jan 2013 | B2 |
8350186 | Jones et al. | Jan 2013 | B2 |
8388667 | Reiley et al. | Mar 2013 | B2 |
8394129 | Morgenstern Lopez et al. | Mar 2013 | B2 |
8398635 | Vaidya | Mar 2013 | B2 |
8414648 | Reiley | Apr 2013 | B2 |
8425570 | Reiley | Apr 2013 | B2 |
8430930 | Hunt | Apr 2013 | B2 |
8444693 | Reiley | May 2013 | B2 |
8449585 | Wallenstein et al. | May 2013 | B2 |
8467851 | Mire et al. | Jun 2013 | B2 |
8470004 | Reiley | Jun 2013 | B2 |
8475505 | Nebosky et al. | Jul 2013 | B2 |
8529608 | Terrill et al. | Sep 2013 | B2 |
8608802 | Bagga et al. | Dec 2013 | B2 |
D697209 | Walthall et al. | Jan 2014 | S |
8641737 | Matthis et al. | Feb 2014 | B2 |
8663332 | To et al. | Mar 2014 | B1 |
8672986 | Klaue et al. | Mar 2014 | B2 |
8734462 | Reiley et al. | May 2014 | B2 |
8778026 | Mauldin | Jul 2014 | B2 |
8840623 | Reiley | Sep 2014 | B2 |
8840651 | Reiley | Sep 2014 | B2 |
8845693 | Smith et al. | Sep 2014 | B2 |
8858601 | Reiley | Oct 2014 | B2 |
8920477 | Reiley | Dec 2014 | B2 |
8945190 | Culbert et al. | Feb 2015 | B2 |
8945193 | Kirschman | Feb 2015 | B2 |
8951254 | Mayer et al. | Feb 2015 | B2 |
8951293 | Glazer et al. | Feb 2015 | B2 |
8951295 | Matityahu et al. | Feb 2015 | B2 |
8961571 | Lee et al. | Feb 2015 | B2 |
8979911 | Martineau et al. | Mar 2015 | B2 |
8986348 | Reiley | Mar 2015 | B2 |
RE45484 | Foley et al. | Apr 2015 | E |
9039743 | Reiley | May 2015 | B2 |
9044321 | Mauldin et al. | Jun 2015 | B2 |
9060876 | To et al. | Jun 2015 | B1 |
9089371 | Faulhaber | Jul 2015 | B1 |
D738498 | Frey et al. | Sep 2015 | S |
9131955 | Swofford | Sep 2015 | B2 |
9149286 | Greenhalgh et al. | Oct 2015 | B1 |
9198676 | Pilgeram et al. | Dec 2015 | B2 |
9220535 | Röbling et al. | Dec 2015 | B2 |
9314348 | Emstad | Apr 2016 | B2 |
9358057 | Whipple et al. | Jun 2016 | B1 |
9375243 | Vestgaarden | Jun 2016 | B1 |
9375323 | Reiley | Jun 2016 | B2 |
9445852 | Sweeney | Sep 2016 | B2 |
9451999 | Simpson et al. | Sep 2016 | B2 |
9452065 | Lawson | Sep 2016 | B1 |
9486264 | Reiley et al. | Nov 2016 | B2 |
9492201 | Reiley | Nov 2016 | B2 |
9498264 | Harshman et al. | Nov 2016 | B2 |
9510872 | Donner et al. | Dec 2016 | B2 |
9517095 | Vaidya | Dec 2016 | B2 |
9526548 | Asfora | Dec 2016 | B2 |
9554909 | Donner | Jan 2017 | B2 |
9561063 | Reiley | Feb 2017 | B2 |
9566100 | Asfora | Feb 2017 | B2 |
9603613 | Schoenefeld et al. | Mar 2017 | B2 |
9603644 | Sweeney | Mar 2017 | B2 |
9615856 | Arnett et al. | Apr 2017 | B2 |
9622783 | Reiley et al. | Apr 2017 | B2 |
9655656 | Whipple | May 2017 | B2 |
9662124 | Assell et al. | May 2017 | B2 |
9662128 | Reiley | May 2017 | B2 |
9662157 | Schneider et al. | May 2017 | B2 |
9662158 | Reiley | May 2017 | B2 |
9675394 | Reiley | Jun 2017 | B2 |
9743969 | Reiley | Aug 2017 | B2 |
9757154 | Donner et al. | Sep 2017 | B2 |
9763695 | Mirda | Sep 2017 | B2 |
9820789 | Reiley | Nov 2017 | B2 |
9839448 | Reckling et al. | Dec 2017 | B2 |
9848892 | Biedermann et al. | Dec 2017 | B2 |
9936983 | Mesiwala et al. | Apr 2018 | B2 |
9949776 | Mobasser et al. | Apr 2018 | B2 |
9949843 | Reiley et al. | Apr 2018 | B2 |
9956013 | Reiley et al. | May 2018 | B2 |
9993276 | Russell | Jun 2018 | B2 |
10004547 | Reiley | Jun 2018 | B2 |
10058430 | Donner et al. | Aug 2018 | B2 |
10166033 | Reiley et al. | Jan 2019 | B2 |
10188442 | Mazel | Jan 2019 | B2 |
10194962 | Schneider et al. | Feb 2019 | B2 |
10201427 | Mauldin et al. | Feb 2019 | B2 |
10219885 | Mamo et al. | Mar 2019 | B2 |
10258380 | Sinha | Apr 2019 | B2 |
10271882 | Biedermann et al. | Apr 2019 | B2 |
10335217 | Lindner | Jul 2019 | B2 |
10363140 | Mauldin et al. | Jul 2019 | B2 |
10426533 | Mauldin et al. | Oct 2019 | B2 |
10492921 | McShane, III et al. | Dec 2019 | B2 |
10531904 | Kolb | Jan 2020 | B2 |
10653454 | Frey et al. | May 2020 | B2 |
10667923 | Sullivan et al. | Jun 2020 | B2 |
10729475 | Childs | Aug 2020 | B2 |
10743995 | Fallin et al. | Aug 2020 | B2 |
D895111 | Frey et al. | Sep 2020 | S |
10758283 | Frey et al. | Sep 2020 | B2 |
10758285 | Geist et al. | Sep 2020 | B2 |
10799367 | Vrionis et al. | Oct 2020 | B2 |
10806597 | Sournac et al. | Oct 2020 | B2 |
10842634 | Pasini et al. | Nov 2020 | B2 |
10856922 | Loke et al. | Dec 2020 | B2 |
10932838 | Mehl et al. | Mar 2021 | B2 |
10940008 | Patel | Mar 2021 | B2 |
10993754 | Kuntz et al. | May 2021 | B2 |
20010012942 | Estes et al. | Aug 2001 | A1 |
20010046518 | Sawhney | Nov 2001 | A1 |
20010047207 | Michelson | Nov 2001 | A1 |
20010049529 | Cachia et al. | Dec 2001 | A1 |
20020019637 | Frey et al. | Feb 2002 | A1 |
20020029043 | Ahrens et al. | Mar 2002 | A1 |
20020038123 | Visotsky et al. | Mar 2002 | A1 |
20020049497 | Mason | Apr 2002 | A1 |
20020077641 | Michelson | Jun 2002 | A1 |
20020082598 | Teitelbaum | Jun 2002 | A1 |
20020120275 | Schmieding et al. | Aug 2002 | A1 |
20020128652 | Ferree | Sep 2002 | A1 |
20020143334 | von Hoffmann et al. | Oct 2002 | A1 |
20020143335 | von Hoffmann et al. | Oct 2002 | A1 |
20020151903 | Takei et al. | Oct 2002 | A1 |
20020169507 | Malone | Nov 2002 | A1 |
20020183858 | Contiliano et al. | Dec 2002 | A1 |
20020198527 | Mückter | Dec 2002 | A1 |
20030018336 | Vandewalle | Jan 2003 | A1 |
20030032961 | Pelo et al. | Feb 2003 | A1 |
20030050642 | Schmieding et al. | Mar 2003 | A1 |
20030065332 | TenHuisen et al. | Apr 2003 | A1 |
20030074000 | Roth et al. | Apr 2003 | A1 |
20030078660 | Clifford et al. | Apr 2003 | A1 |
20030083668 | Rogers et al. | May 2003 | A1 |
20030083688 | Simonson | May 2003 | A1 |
20030088251 | Braun et al. | May 2003 | A1 |
20030097131 | Schon et al. | May 2003 | A1 |
20030139815 | Grooms et al. | Jul 2003 | A1 |
20030181979 | Ferree | Sep 2003 | A1 |
20030181982 | Kuslich | Sep 2003 | A1 |
20030199983 | Michelson | Oct 2003 | A1 |
20030229358 | Errico et al. | Dec 2003 | A1 |
20030233146 | Grinberg et al. | Dec 2003 | A1 |
20030233147 | Nicholson et al. | Dec 2003 | A1 |
20040010315 | Song | Jan 2004 | A1 |
20040015172 | Biedermann | Jan 2004 | A1 |
20040024458 | Senegas et al. | Feb 2004 | A1 |
20040034422 | Errico et al. | Feb 2004 | A1 |
20040073216 | Lieberman | Apr 2004 | A1 |
20040073314 | White et al. | Apr 2004 | A1 |
20040082955 | Zirkle | Apr 2004 | A1 |
20040087948 | Suddaby | May 2004 | A1 |
20040097927 | Yeung et al. | May 2004 | A1 |
20040106925 | Culbert | Jun 2004 | A1 |
20040117022 | Marnay et al. | Jun 2004 | A1 |
20040127990 | Bartish, Jr. et al. | Jul 2004 | A1 |
20040138750 | Mitchell | Jul 2004 | A1 |
20040138753 | Ferree | Jul 2004 | A1 |
20040147929 | Biedermann et al. | Jul 2004 | A1 |
20040158324 | Lange | Aug 2004 | A1 |
20040176287 | Harrison et al. | Sep 2004 | A1 |
20040176853 | Sennett et al. | Sep 2004 | A1 |
20040181282 | Zucherman et al. | Sep 2004 | A1 |
20040186572 | Lange et al. | Sep 2004 | A1 |
20040210221 | Kozak et al. | Oct 2004 | A1 |
20040225360 | Malone | Nov 2004 | A1 |
20040230305 | Gorensek et al. | Nov 2004 | A1 |
20040260286 | Ferree | Dec 2004 | A1 |
20040267369 | Lyons et al. | Dec 2004 | A1 |
20050015059 | Sweeney | Jan 2005 | A1 |
20050015146 | Louis et al. | Jan 2005 | A1 |
20050033435 | Belliard et al. | Feb 2005 | A1 |
20050049590 | Alleyne et al. | Mar 2005 | A1 |
20050055023 | Sohngen et al. | Mar 2005 | A1 |
20050075641 | Singhatat et al. | Apr 2005 | A1 |
20050080415 | Keyer et al. | Apr 2005 | A1 |
20050107878 | Conchy | May 2005 | A1 |
20050112397 | Rolfe et al. | May 2005 | A1 |
20050124993 | Chappuis | Jun 2005 | A1 |
20050131409 | Chervitz et al. | Jun 2005 | A1 |
20050137605 | Assell et al. | Jun 2005 | A1 |
20050143837 | Ferree | Jun 2005 | A1 |
20050149192 | Zucherman et al. | Jul 2005 | A1 |
20050159749 | Levy et al. | Jul 2005 | A1 |
20050159812 | Dinger et al. | Jul 2005 | A1 |
20050165398 | Reiley | Jul 2005 | A1 |
20050192572 | Abdelgany et al. | Sep 2005 | A1 |
20050216082 | Wilson et al. | Sep 2005 | A1 |
20050228384 | Zucherman et al. | Oct 2005 | A1 |
20050246021 | Ringeisen et al. | Nov 2005 | A1 |
20050251146 | Martz et al. | Nov 2005 | A1 |
20050273101 | Schumacher | Dec 2005 | A1 |
20050277940 | Neff | Dec 2005 | A1 |
20060036247 | Michelson | Feb 2006 | A1 |
20060036251 | Reiley | Feb 2006 | A1 |
20060036252 | Baynham et al. | Feb 2006 | A1 |
20060054171 | Dall | Mar 2006 | A1 |
20060058793 | Michelson | Mar 2006 | A1 |
20060058800 | Ainsworth et al. | Mar 2006 | A1 |
20060062825 | Maccecchini | Mar 2006 | A1 |
20060084986 | Grinberg et al. | Apr 2006 | A1 |
20060089656 | Allard et al. | Apr 2006 | A1 |
20060111779 | Petersen | May 2006 | A1 |
20060129247 | Brown et al. | Jun 2006 | A1 |
20060142772 | Ralph et al. | Jun 2006 | A1 |
20060161163 | Shino | Jul 2006 | A1 |
20060178673 | Curran | Aug 2006 | A1 |
20060195094 | McGraw et al. | Aug 2006 | A1 |
20060217717 | Whipple | Sep 2006 | A1 |
20060241776 | Brown et al. | Oct 2006 | A1 |
20060271054 | Sucec et al. | Nov 2006 | A1 |
20060293662 | Boyer, II et al. | Dec 2006 | A1 |
20070027544 | McCord et al. | Feb 2007 | A1 |
20070038219 | Matthis et al. | Feb 2007 | A1 |
20070049933 | Ahn et al. | Mar 2007 | A1 |
20070066977 | Assell et al. | Mar 2007 | A1 |
20070083265 | Malone | Apr 2007 | A1 |
20070088362 | Bonutti et al. | Apr 2007 | A1 |
20070093841 | Hoogland | Apr 2007 | A1 |
20070093898 | Schwab et al. | Apr 2007 | A1 |
20070106383 | Abdou | May 2007 | A1 |
20070149976 | Hale et al. | Jun 2007 | A1 |
20070156144 | Ulrich et al. | Jul 2007 | A1 |
20070156241 | Reiley et al. | Jul 2007 | A1 |
20070156246 | Meswania et al. | Jul 2007 | A1 |
20070161989 | Heinz et al. | Jul 2007 | A1 |
20070173820 | Trieu | Jul 2007 | A1 |
20070219634 | Greenhalgh et al. | Sep 2007 | A1 |
20070233080 | Na et al. | Oct 2007 | A1 |
20070233146 | Henniges et al. | Oct 2007 | A1 |
20070233247 | Schwab | Oct 2007 | A1 |
20070250166 | McKay | Oct 2007 | A1 |
20070270879 | Isaza et al. | Nov 2007 | A1 |
20070282443 | Globerman et al. | Dec 2007 | A1 |
20080021454 | Chao et al. | Jan 2008 | A1 |
20080021455 | Chao et al. | Jan 2008 | A1 |
20080021456 | Gupta et al. | Jan 2008 | A1 |
20080021461 | Barker et al. | Jan 2008 | A1 |
20080021480 | Chin et al. | Jan 2008 | A1 |
20080065093 | Assell et al. | Mar 2008 | A1 |
20080065215 | Reiley | Mar 2008 | A1 |
20080071356 | Greenhalgh et al. | Mar 2008 | A1 |
20080109083 | Van Hoeck et al. | May 2008 | A1 |
20080132901 | Recoules-Arche et al. | Jun 2008 | A1 |
20080140082 | Erdem et al. | Jun 2008 | A1 |
20080147079 | Chin et al. | Jun 2008 | A1 |
20080154374 | Labrom | Jun 2008 | A1 |
20080161810 | Melkent | Jul 2008 | A1 |
20080183204 | Greenhalgh et al. | Jul 2008 | A1 |
20080234758 | Fisher et al. | Sep 2008 | A1 |
20080255562 | Gil et al. | Oct 2008 | A1 |
20080255618 | Fisher et al. | Oct 2008 | A1 |
20080255622 | Mickiewicz et al. | Oct 2008 | A1 |
20080255664 | Hogendijk et al. | Oct 2008 | A1 |
20080255666 | Fisher et al. | Oct 2008 | A1 |
20080255667 | Horton | Oct 2008 | A1 |
20080275454 | Geibel | Nov 2008 | A1 |
20080294202 | Peterson et al. | Nov 2008 | A1 |
20080306554 | McKinley | Dec 2008 | A1 |
20090012529 | Blain et al. | Jan 2009 | A1 |
20090018660 | Roush | Jan 2009 | A1 |
20090024174 | Stark | Jan 2009 | A1 |
20090036927 | Vestgaarden | Feb 2009 | A1 |
20090037148 | Lin et al. | Feb 2009 | A1 |
20090043393 | Duggal et al. | Feb 2009 | A1 |
20090082810 | Bhatnagar et al. | Mar 2009 | A1 |
20090082869 | Slemker et al. | Mar 2009 | A1 |
20090099602 | Aflatoon | Apr 2009 | A1 |
20090099610 | Johnson et al. | Apr 2009 | A1 |
20090105770 | Berrevooets et al. | Apr 2009 | A1 |
20090118771 | Gonzalez-Hernandez | May 2009 | A1 |
20090131986 | Lee et al. | May 2009 | A1 |
20090138053 | Assell et al. | May 2009 | A1 |
20090157119 | Hale | Jun 2009 | A1 |
20090163920 | Hochschuler et al. | Jun 2009 | A1 |
20090187247 | Metcalf, Jr. et al. | Jul 2009 | A1 |
20090216238 | Stark | Aug 2009 | A1 |
20090270929 | Suddaby | Oct 2009 | A1 |
20090287254 | Nayet et al. | Nov 2009 | A1 |
20090312798 | Varela | Dec 2009 | A1 |
20090324678 | Thorne et al. | Dec 2009 | A1 |
20100003638 | Collins | Jan 2010 | A1 |
20100022535 | Lee et al. | Jan 2010 | A1 |
20100076502 | Guyer et al. | Mar 2010 | A1 |
20100081107 | Bagambissa et al. | Apr 2010 | A1 |
20100094290 | Vaidya | Apr 2010 | A1 |
20100094295 | Schnieders et al. | Apr 2010 | A1 |
20100094420 | Grohowski | Apr 2010 | A1 |
20100106194 | Bonutti et al. | Apr 2010 | A1 |
20100106195 | Serhan et al. | Apr 2010 | A1 |
20100114174 | Jones et al. | May 2010 | A1 |
20100114317 | Lambrecht et al. | May 2010 | A1 |
20100131011 | Stark | May 2010 | A1 |
20100137990 | Apatsidis et al. | Jun 2010 | A1 |
20100145461 | Landry et al. | Jun 2010 | A1 |
20100160977 | Gephart et al. | Jun 2010 | A1 |
20100168798 | Clineff et al. | Jul 2010 | A1 |
20100191292 | DeMeo et al. | Jul 2010 | A1 |
20100268228 | Petersen | Oct 2010 | A1 |
20100280619 | Yuan et al. | Nov 2010 | A1 |
20100280622 | McKinley | Nov 2010 | A1 |
20100286778 | Eisermann et al. | Nov 2010 | A1 |
20100331851 | Huene | Dec 2010 | A1 |
20100331893 | Geist et al. | Dec 2010 | A1 |
20110009869 | Marino et al. | Jan 2011 | A1 |
20110022089 | Assell et al. | Jan 2011 | A1 |
20110029019 | Ainsworth et al. | Feb 2011 | A1 |
20110040362 | Godara et al. | Feb 2011 | A1 |
20110046737 | Teisen | Feb 2011 | A1 |
20110060373 | Russell et al. | Mar 2011 | A1 |
20110060375 | Bonutti | Mar 2011 | A1 |
20110066190 | Schaller et al. | Mar 2011 | A1 |
20110082551 | Kraus | Apr 2011 | A1 |
20110093020 | Wu | Apr 2011 | A1 |
20110098747 | Donner et al. | Apr 2011 | A1 |
20110098816 | Jacob et al. | Apr 2011 | A1 |
20110098817 | Eckhardt et al. | Apr 2011 | A1 |
20110106175 | Rezach | May 2011 | A1 |
20110153018 | Walters et al. | Jun 2011 | A1 |
20110160866 | Laurence et al. | Jun 2011 | A1 |
20110178561 | Roh | Jul 2011 | A1 |
20110184518 | Trieu | Jul 2011 | A1 |
20110184519 | Trieu | Jul 2011 | A1 |
20110184520 | Trieu | Jul 2011 | A1 |
20110196372 | Murase | Aug 2011 | A1 |
20110230966 | Trieu | Sep 2011 | A1 |
20110238074 | Ek | Sep 2011 | A1 |
20110238181 | Trieu | Sep 2011 | A1 |
20110245930 | Alley et al. | Oct 2011 | A1 |
20110257755 | Bellemere et al. | Oct 2011 | A1 |
20110264229 | Donner | Oct 2011 | A1 |
20110276098 | Biedermann et al. | Nov 2011 | A1 |
20110295272 | Assell et al. | Dec 2011 | A1 |
20110295370 | Suh et al. | Dec 2011 | A1 |
20110313471 | McLean et al. | Dec 2011 | A1 |
20110313532 | Hunt | Dec 2011 | A1 |
20110319995 | Voellmicke et al. | Dec 2011 | A1 |
20120004730 | Castro | Jan 2012 | A1 |
20120083887 | Purcell et al. | Apr 2012 | A1 |
20120095560 | Donner | Apr 2012 | A1 |
20120179256 | Reiley | Jul 2012 | A1 |
20120191191 | Trieu | Jul 2012 | A1 |
20120226318 | Wenger et al. | Sep 2012 | A1 |
20120253398 | Metcalf et al. | Oct 2012 | A1 |
20120259372 | Glazer et al. | Oct 2012 | A1 |
20120271424 | Crawford | Oct 2012 | A1 |
20120277866 | Kalluri et al. | Nov 2012 | A1 |
20120296428 | Donner | Nov 2012 | A1 |
20120323285 | Assell et al. | Dec 2012 | A1 |
20130018427 | Pham et al. | Jan 2013 | A1 |
20130030456 | Assell et al. | Jan 2013 | A1 |
20130030529 | Hunt | Jan 2013 | A1 |
20130035727 | Datta | Feb 2013 | A1 |
20130053852 | Greenhalgh et al. | Feb 2013 | A1 |
20130053854 | Schoenefeld et al. | Feb 2013 | A1 |
20130053902 | Trudeau | Feb 2013 | A1 |
20130053963 | Davenport | Feb 2013 | A1 |
20130072984 | Robinson | Mar 2013 | A1 |
20130085535 | Greenhalgh et al. | Apr 2013 | A1 |
20130096683 | Kube | Apr 2013 | A1 |
20130116793 | Kloss | May 2013 | A1 |
20130123850 | Schoenefeld et al. | May 2013 | A1 |
20130123935 | Hunt et al. | May 2013 | A1 |
20130131678 | Dahners | May 2013 | A1 |
20130144343 | Arnett et al. | Jun 2013 | A1 |
20130158609 | Mikhail et al. | Jun 2013 | A1 |
20130172736 | Abdou | Jul 2013 | A1 |
20130197590 | Assell et al. | Aug 2013 | A1 |
20130203088 | Baerlecken et al. | Aug 2013 | A1 |
20130218215 | Ginn et al. | Aug 2013 | A1 |
20130218282 | Hunt | Aug 2013 | A1 |
20130231746 | Ginn et al. | Sep 2013 | A1 |
20130237988 | Mauldin | Sep 2013 | A1 |
20130245703 | Warren et al. | Sep 2013 | A1 |
20130245763 | Mauldin | Sep 2013 | A1 |
20130267836 | Mauldin et al. | Oct 2013 | A1 |
20130267961 | Mauldin et al. | Oct 2013 | A1 |
20130267989 | Mauldin et al. | Oct 2013 | A1 |
20130274890 | McKay | Oct 2013 | A1 |
20130325129 | Huang | Dec 2013 | A1 |
20140012334 | Armstrong et al. | Jan 2014 | A1 |
20140012340 | Beck et al. | Jan 2014 | A1 |
20140031934 | Trieu | Jan 2014 | A1 |
20140031935 | Donner et al. | Jan 2014 | A1 |
20140031938 | Lechmann et al. | Jan 2014 | A1 |
20140031939 | Wolfe et al. | Jan 2014 | A1 |
20140046380 | Asfora | Feb 2014 | A1 |
20140074175 | Ehler et al. | Mar 2014 | A1 |
20140088596 | Assell et al. | Mar 2014 | A1 |
20140088707 | Donner et al. | Mar 2014 | A1 |
20140121776 | Hunt | May 2014 | A1 |
20140135927 | Pavlov et al. | May 2014 | A1 |
20140142700 | Donner et al. | May 2014 | A1 |
20140172027 | Biedermann et al. | Jun 2014 | A1 |
20140200618 | Donner et al. | Jul 2014 | A1 |
20140207240 | Stoffman et al. | Jul 2014 | A1 |
20140257294 | Gedet et al. | Sep 2014 | A1 |
20140257408 | Trieu et al. | Sep 2014 | A1 |
20140276846 | Mauldin et al. | Sep 2014 | A1 |
20140276851 | Schneider et al. | Sep 2014 | A1 |
20140277139 | Vrionis | Sep 2014 | A1 |
20140277165 | Katzman et al. | Sep 2014 | A1 |
20140277460 | Schifano et al. | Sep 2014 | A1 |
20140277462 | Yerby et al. | Sep 2014 | A1 |
20140277463 | Yerby et al. | Sep 2014 | A1 |
20140288649 | Hunt | Sep 2014 | A1 |
20140288650 | Hunt | Sep 2014 | A1 |
20140296982 | Cheng | Oct 2014 | A1 |
20140330382 | Mauldin | Nov 2014 | A1 |
20140364917 | Sandstrom et al. | Dec 2014 | A1 |
20150012051 | Warren et al. | Jan 2015 | A1 |
20150039037 | Donner et al. | Feb 2015 | A1 |
20150080951 | Yeh | Mar 2015 | A1 |
20150080972 | Chin et al. | Mar 2015 | A1 |
20150094765 | Donner et al. | Apr 2015 | A1 |
20150112444 | Aksu | Apr 2015 | A1 |
20150147397 | Altschuler | May 2015 | A1 |
20150150683 | Donner et al. | Jun 2015 | A1 |
20150173805 | Donner et al. | Jun 2015 | A1 |
20150173904 | Stark | Jun 2015 | A1 |
20150182268 | Donner et al. | Jul 2015 | A1 |
20150190149 | Assell et al. | Jul 2015 | A1 |
20150190187 | Parent et al. | Jul 2015 | A1 |
20150209094 | Anderson | Jul 2015 | A1 |
20150216566 | Mikhail et al. | Aug 2015 | A1 |
20150238203 | Asfora | Aug 2015 | A1 |
20150250513 | De Lavigne Sainte | Sep 2015 | A1 |
20150250611 | Schifano et al. | Sep 2015 | A1 |
20150250612 | Schifano et al. | Sep 2015 | A1 |
20150257892 | Lechmann et al. | Sep 2015 | A1 |
20150313720 | Lorio | Nov 2015 | A1 |
20150320450 | Mootien et al. | Nov 2015 | A1 |
20150320451 | Mootien et al. | Nov 2015 | A1 |
20150320469 | Biedermann et al. | Nov 2015 | A1 |
20150342753 | Donner et al. | Dec 2015 | A1 |
20160000488 | Cross, III | Jan 2016 | A1 |
20160022429 | Greenhalgh et al. | Jan 2016 | A1 |
20160095711 | Castro | Apr 2016 | A1 |
20160095721 | Schell et al. | Apr 2016 | A1 |
20160100870 | Lavigne et al. | Apr 2016 | A1 |
20160106477 | Hynes et al. | Apr 2016 | A1 |
20160106479 | Hynes et al. | Apr 2016 | A1 |
20160120661 | Schell et al. | May 2016 | A1 |
20160143671 | Jimenez | May 2016 | A1 |
20160157908 | Cawley et al. | Jun 2016 | A1 |
20160175113 | Lins | Jun 2016 | A1 |
20160184103 | Fonte et al. | Jun 2016 | A1 |
20160213487 | Wison et al. | Jul 2016 | A1 |
20160242820 | Whipple et al. | Aug 2016 | A1 |
20160242912 | Lindsey et al. | Aug 2016 | A1 |
20160249940 | Stark | Sep 2016 | A1 |
20160287171 | Sand et al. | Oct 2016 | A1 |
20160287301 | Mehl et al. | Oct 2016 | A1 |
20160310188 | Marino et al. | Oct 2016 | A1 |
20160310197 | Black et al. | Oct 2016 | A1 |
20160324643 | Donner et al. | Nov 2016 | A1 |
20160324656 | Moris et al. | Nov 2016 | A1 |
20160374727 | Greenhalgh et al. | Dec 2016 | A1 |
20170014235 | Jones et al. | Jan 2017 | A1 |
20170020573 | Cain et al. | Jan 2017 | A1 |
20170020585 | Harshman et al. | Jan 2017 | A1 |
20170049488 | Vestgaarden | Feb 2017 | A1 |
20170086885 | Duncan et al. | Mar 2017 | A1 |
20170128083 | Germain | May 2017 | A1 |
20170128214 | Mayer | May 2017 | A1 |
20170135733 | Donner et al. | May 2017 | A1 |
20170143513 | Sandstrom et al. | May 2017 | A1 |
20170156879 | Janowski | Jun 2017 | A1 |
20170156880 | Halverson et al. | Jun 2017 | A1 |
20170202511 | Chang et al. | Jul 2017 | A1 |
20170209155 | Petersen | Jul 2017 | A1 |
20170216036 | Cordaro | Aug 2017 | A1 |
20170224393 | Lavigne et al. | Aug 2017 | A1 |
20170246000 | Pavlov et al. | Aug 2017 | A1 |
20170258498 | Redmond et al. | Sep 2017 | A1 |
20170258506 | Redmond et al. | Sep 2017 | A1 |
20170258606 | Afzal | Sep 2017 | A1 |
20170266007 | Gelaude et al. | Sep 2017 | A1 |
20170296344 | Souza et al. | Oct 2017 | A1 |
20170303938 | Rindal et al. | Oct 2017 | A1 |
20170333205 | Joly et al. | Nov 2017 | A1 |
20180104063 | Asaad | Apr 2018 | A1 |
20180104068 | Sack | Apr 2018 | A1 |
20180104071 | Reckling et al. | Apr 2018 | A1 |
20180110624 | Arnone | Apr 2018 | A1 |
20180110626 | McShane, III et al. | Apr 2018 | A1 |
20180177534 | Mesiwala et al. | Jun 2018 | A1 |
20180199970 | Beck et al. | Jul 2018 | A1 |
20180200063 | Kahmer et al. | Jul 2018 | A1 |
20180214192 | Roby et al. | Aug 2018 | A1 |
20180228613 | Jones et al. | Aug 2018 | A1 |
20180228617 | Srour et al. | Aug 2018 | A1 |
20180228621 | Reiley et al. | Aug 2018 | A1 |
20180243097 | Jones et al. | Aug 2018 | A1 |
20180256351 | Bishop et al. | Sep 2018 | A1 |
20180256352 | Nyahay et al. | Sep 2018 | A1 |
20180256361 | Bishop et al. | Sep 2018 | A1 |
20180280139 | Jones et al. | Oct 2018 | A1 |
20180280140 | Jones et al. | Oct 2018 | A1 |
20180296363 | Berry | Oct 2018 | A1 |
20180303623 | Shoshtaev | Oct 2018 | A1 |
20180303624 | Shoshtaev | Oct 2018 | A1 |
20180317971 | Prevost | Nov 2018 | A1 |
20180368894 | Wieland et al. | Dec 2018 | A1 |
20190000636 | Kim et al. | Jan 2019 | A1 |
20190008562 | Melton et al. | Jan 2019 | A1 |
20190076258 | Black et al. | Mar 2019 | A1 |
20190076266 | Trudeau et al. | Mar 2019 | A1 |
20190083270 | Milz et al. | Mar 2019 | A1 |
20190090888 | Sand et al. | Mar 2019 | A1 |
20190091027 | Asaad et al. | Mar 2019 | A1 |
20190125408 | Asfora et al. | May 2019 | A1 |
20190133613 | Reiley et al. | May 2019 | A1 |
20190133769 | Tetsworth et al. | May 2019 | A1 |
20190133783 | Unger et al. | May 2019 | A1 |
20190142606 | Freudenberger | May 2019 | A1 |
20190150910 | Jones et al. | May 2019 | A1 |
20190151113 | Sack | May 2019 | A1 |
20190151114 | Sack | May 2019 | A1 |
20190159818 | Schneider et al. | May 2019 | A1 |
20190159901 | Mauldin et al. | May 2019 | A1 |
20190183653 | Gregersen et al. | Jun 2019 | A1 |
20190231554 | Bishop et al. | Aug 2019 | A1 |
20190239935 | Willis et al. | Aug 2019 | A1 |
20190254840 | Gray et al. | Aug 2019 | A1 |
20190262048 | Sutika | Aug 2019 | A1 |
20190262049 | Tempco et al. | Aug 2019 | A1 |
20190290441 | Tong et al. | Sep 2019 | A1 |
20190298528 | Lindsey et al. | Oct 2019 | A1 |
20190298542 | Kloss | Oct 2019 | A1 |
20190328546 | Palagi et al. | Oct 2019 | A1 |
20190343564 | Tempco et al. | Nov 2019 | A1 |
20190343565 | Tempco et al. | Nov 2019 | A1 |
20190343566 | Tempco et al. | Nov 2019 | A1 |
20190343567 | Tempco et al. | Nov 2019 | A1 |
20190343640 | Donner et al. | Nov 2019 | A1 |
20190343641 | Mauldin et al. | Nov 2019 | A1 |
20190343644 | Ryan et al. | Nov 2019 | A1 |
20190343645 | Miccio et al. | Nov 2019 | A1 |
20190343652 | Petersheim et al. | Nov 2019 | A1 |
20190343653 | McKay | Nov 2019 | A1 |
20190388131 | Mehl et al. | Dec 2019 | A1 |
20190388242 | Harris et al. | Dec 2019 | A1 |
20200000595 | Jones et al. | Jan 2020 | A1 |
20200008817 | Reiley et al. | Jan 2020 | A1 |
20200008850 | Mauldin et al. | Jan 2020 | A1 |
20200038069 | Jones et al. | Feb 2020 | A1 |
20200046512 | Newman et al. | Feb 2020 | A1 |
20200093603 | Manwill et al. | Mar 2020 | A1 |
20200100822 | Lipow | Apr 2020 | A1 |
20200129214 | Pepper et al. | Apr 2020 | A1 |
20200138485 | Kuwamura et al. | May 2020 | A1 |
20200138492 | Kavanagh | May 2020 | A1 |
20200170679 | Sciubba et al. | Jun 2020 | A1 |
20200246158 | Bergey | Aug 2020 | A1 |
20200261240 | Mesiwala et al. | Aug 2020 | A1 |
20200268518 | Suh et al. | Aug 2020 | A1 |
20200323563 | Rezach et al. | Oct 2020 | A1 |
20200345507 | Reiley | Nov 2020 | A1 |
20200345508 | Reiley | Nov 2020 | A1 |
20200345509 | Reiley | Nov 2020 | A1 |
20200345510 | Reiley | Nov 2020 | A1 |
20200375750 | Abbasi et al. | Dec 2020 | A1 |
20200397491 | Frey et al. | Dec 2020 | A1 |
20210107093 | Tempco | Apr 2021 | A1 |
20210153911 | Stuart et al. | May 2021 | A1 |
20210169660 | Reckling et al. | Jun 2021 | A1 |
20210212734 | Mesiwala et al. | Jul 2021 | A1 |
Number | Date | Country |
---|---|---|
1128944 | Aug 1996 | CN |
1190882 | Aug 1998 | CN |
1909848 | Feb 2007 | CN |
101795632 | Aug 2010 | CN |
102361601 | Feb 2012 | CN |
102011001264 | Sep 2012 | DE |
102012106336 | Jan 2014 | DE |
1287796 | Mar 2003 | EP |
2070481 | Feb 2012 | EP |
2590576 | Oct 2015 | EP |
2749238 | Mar 2017 | EP |
2887899 | Aug 2017 | EP |
2341852 | Aug 2018 | EP |
2496162 | Oct 2018 | EP |
3484387 | May 2019 | EP |
3593745 | Jan 2020 | EP |
3616634 | Mar 2020 | EP |
3661441 | Jun 2020 | EP |
2408389 | Apr 2021 | EP |
59200642 | Nov 1984 | JP |
05-176942 | Jul 1993 | JP |
05184615 | Jul 1993 | JP |
09149906 | Oct 1997 | JP |
10-85231 | Apr 1998 | JP |
11318931 | Nov 1999 | JP |
2002509753 | Apr 2002 | JP |
2003511198 | Mar 2003 | JP |
2003533329 | Nov 2003 | JP |
2003534046 | Nov 2003 | JP |
2004121841 | Apr 2004 | JP |
2004512895 | Apr 2004 | JP |
2004516866 | Jun 2004 | JP |
2006506181 | Feb 2006 | JP |
2007535973 | Dec 2007 | JP |
2008540036 | Nov 2008 | JP |
2009521990 | Jun 2009 | JP |
2009533159 | Sep 2009 | JP |
2010137016 | Jun 2010 | JP |
2015510506 | Apr 2015 | JP |
WO9731517 | Aug 1997 | WO |
WO 0117445 | Mar 2001 | WO |
WO0238054 | May 2002 | WO |
WO03007839 | Jan 2003 | WO |
WO0402344 | Jan 2004 | WO |
WO2004043277 | May 2004 | WO |
WO2005009729 | Feb 2005 | WO |
WO2006003316 | Jan 2006 | WO |
WO2006023793 | Mar 2006 | WO |
WO2006074321 | Jul 2006 | WO |
WO2009029074 | Mar 2009 | WO |
WO2010105196 | Sep 2010 | WO |
WO2011010463 | Jan 2011 | WO |
WO2011110865 | Sep 2011 | WO |
WO2011124874 | Oct 2011 | WO |
WO2011149557 | Dec 2011 | WO |
WO2013000071 | Jan 2013 | WO |
WO2013119907 | Aug 2013 | WO |
WO2020168269 | Aug 2020 | WO |
WO2021102429 | May 2021 | WO |
Entry |
---|
ACUMED: Acutrak Headless Compressioin Screw (product information); 12 pgs; © 2005; retrieved Sep. 25, 2014 from http://www.rcsed.ac.uk/fellows/Ivanrensburg/classification/surgtech/acumed/manuals/acutrak-brochure%200311.pdf. |
Al-Khayer et al.; Percutaneous sacroiliac joint arthrodesis, a novel technique; J Spinal Disord Tech; vol. 21; No. 5; pp. 359-363; Jul. 2008. |
Khurana et al.; Percutaneous fusion of the sacroiliac joint with hollow modular anchorage screws, clinical and radiological outcome; J Bone Joint Surg; vol. 91-B, No. 5; pp. 627-631; May 2009. |
Lu et al.: Mechanical properties of porous materials; Journal of Porous Materials; 6(4); pp. 359-368; Nov. 1, 1999. |
Peretz et al.; The internal bony architecture of the sacrum; Spine; 23(9); pp. 971-974; May 1, 1998. |
Richards et al.; Bone density and cortical thickness in normal, osteopenic, and osteoporotic sacra; Journal of Osteoporosis; 2010(ID 504078); 5 pgs; Jun. 9, 2010. |
Wise et al.; Minimally invasive sacroiliac arthrodesis, outcomes of a new technique; J Spinal Disord Tech; vol. 21; No. 8; pp. 579-584; Dec. 2008. |
Number | Date | Country | |
---|---|---|---|
20200268525 A1 | Aug 2020 | US |
Number | Date | Country | |
---|---|---|---|
62933250 | Nov 2019 | US | |
62859646 | Jun 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2020/018402 | Feb 2020 | US |
Child | 16874149 | US | |
Parent | 16276430 | Feb 2019 | US |
Child | PCT/US2020/018402 | US |